Status:
UNKNOWN
Comparison of BL and KTP Laser for Treatment of Benign Vocal Fold Lesions
Lead Sponsor:
University of Toronto
Conditions:
Voice Disorders
RRP
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Preliminary investigations suggest that a novel blue light (BL) laser with a wavelength of 445nm is comparable to the commonly utilized KTP laser (532nm) for treatment of laryngeal pathologies. An ani...
Detailed Description
A novel blue light (BL) laser, TruBlue surgical laser, has recently been approved by Health Canada for use in the larynx. It has a wavelength of 445nm, which is within the same visible light spectrum ...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form;
- Stated willingness to comply with all study procedures and availability for the duration of the study;
- Male and female, aged ≥ 18 years; and
- Diagnosed with benign vocal fold lesions such as papillomas and polyps and who are candidates for elective in office laser treatment for these lesions.
Exclusion
- \< 18 years old;
- Current smokers;
- Vocal fold lesions such as vocal fold leukoplakia and vocal fold cancer;
- Systemic steroid use; and
- History of systemic illness that can affect wound healing.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04513392
Start Date
November 1 2020
End Date
November 1 2021
Last Update
August 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.